Cookie Notice

This site uses cookies. By continuing to browse this site, you are agreeing to our use of cookies. Review our cookies information for more details.

OK
MENU
Back to Top

World Alzheimer's Day 2022

Dear Colleagues,

We have all seen the statistics:

  • There are an estimated 50 million people worldwide living with Alzheimer’s and other dementias

  • Current projections put this number upwards of 150 million by 2050

While research shows early diagnosis can mean early treatment options; stigma, misdiagnosis and misinformation remain commonplace. It is for this reason that Alzheimer’s Disease International (ADI) has set their 2022 theme as “Know Dementia, Know Alzheimer's” and “will have a special focus on post-diagnostic support.”

The International Psychogeriatric Association (IPA) publishes numerous academic articles, reports, editorials and research papers around Alzheimer’s disease and other dementias every year. Yet we must not forget the importance of raising public awareness of dementia as well combating the stigma of ageism, mentalism, and ableism.  This 21 September, we call once again on our members and colleagues to join us in supporting World Alzheimer’s Day. Click here to see the resource materials created by ADI. And their World Alzheimer Report 2022 is now available in PDF form.

Launched by ADI in 2012, World Alzheimer’s Month is held every September to “raise awareness and challenge the stigma that surrounds dementia.” 21 September is recognized as World Alzheimer’s Day.

http://www.execinc.com/hosted/emails/ipa/image/headshots/Rabheru.updatedheadshot.100x125.jpg

 

 

Kiran Rabheru, MD, CCFP, FRCP, DABPN
IPA Board of Directors
Chair, IPA Advocacy Committee

Acknowledgements

Acadia Pharmaceuticals Avanir Pharmaceuticals Cambridge University Press Otsuka Pharmaceuticals
CORPORATE COUNCILS